Purchases and Sales Made in Q2 2022 in Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN) during Q2 2022. The information is specifically focused on institutions that hold shares of REGENERON PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-135K- 67.79% |
$74.2M - $100M
|
64.3K
$31.5M
|
|
|
Aug 15, 2022
Q2 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-207KClosed |
$114M - $153M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-210K- 42.97% |
$115M - $155M
|
279K
$137M
|
|
|
Aug 15, 2022
Q2 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-507K- 17.55% |
$278M - $375M
|
2.38M
$1.17B
|
|
|
Aug 15, 2022
Q2 2022
|
Harris Associates L P
Chicago, IL |
SELL
|
- |
-510K- 46.7% |
$280M - $377M
|
583K
$286M
|
|
|
Aug 05, 2022
Q2 2022
|
Loomis Sayles & CO L P
|
SELL
|
- |
-783K- 30.74% |
$430M - $579M
|
1.76M
$865M
|